Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Johnson and Johnson
Medtronic
Healthtrust
UBS
Daiichi Sankyo
Argus Health
Julphar

Generated: September 23, 2018

DrugPatentWatch Database Preview

Hetacillin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hetacillin and what is the scope of hetacillin patent protection?

Hetacillin is the generic ingredient in two branded drugs marketed by Bristol and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for hetacillin.

Summary for hetacillin
US Patents:0
Tradenames:2
Applicants:1
NDAs:3
Drug Master File Entries: 6
Bulk Api Vendors: 20
Patent Applications: 2,572
DailyMed Link:hetacillin at DailyMed
Synonyms for hetacillin
(2S,%R,6R)-6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carbonsaeure
(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
3511-16-8
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-
6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillansaeure
6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-2,2-dimethylpenam-3alpha-carboxylic acid
6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid
7-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-6-oxo-2-thia-5-azabicyclo[3.2.0]heptane-4-carboxylic acid
AC1L9EKH
AKOS027381814
BL-P 804
BL-P-804
BRL 804
BRL-804
C-23897
C11729
CC-29245
CHEBI:5683
CHEMBL1201116
CS-4870
D01074
DB00739
DR002253
DXVUYOAEDJXBPY-NFFDBFGFSA-N
EINECS 222-512-5
etacillin
Etacillina
Etacillina [DCIT]
FT-0771485
HE337458
Hetacilina
Hetacilina [INN-Spanish]
Hetacillin (USAN/INN)
Hetacillin [USAN:USP:INN:BAN]
Hetacilline
Hetacilline [INN-French]
Hetacillinum
Hetacillinum [INN-Latin]
HY-16251A
N,N'-Isopropylidene-A-amino-benzyl penicillin
N.N'-Isopropylidene-A-amino-benzyl penicillin
penplenum
Phenazacillin
SCHEMBL34131
TN4JSC48CV
UNII-TN4JSC48CV
Versapen
Versapen (TN)
Versapen-k
ZINC4102186

US Patents and Regulatory Information for hetacillin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol VERSAPEN hetacillin FOR SUSPENSION;ORAL 050060-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol VERSAPEN-K hetacillin potassium CAPSULE;ORAL 061396-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol VERSAPEN-K hetacillin potassium CAPSULE;ORAL 061396-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol VERSAPEN hetacillin FOR SUSPENSION;ORAL 061398-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Johnson and Johnson
Medtronic
Healthtrust
UBS
Daiichi Sankyo
Argus Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.